Research team led by Dr. Daniel Haber to explore applicability of Helicos’s technology to the molecular characterization of circulating tumor cells CAMBRIDGE, Mass.–Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, today announced the placement of a Helicos™ Genetic Analysis System at the Massachusetts General Hospital (MGH) Cancer Center […]
Monsanto and Wellcome Trust Among New Investors MENLO PARK, Calif.–Pacific Biosciences, a private company pioneering the development of a transformative DNA sequencing technology, announced today it has raised an additional $68 million in financing. The current financing comes from a combination of new and previous investors, including strategic investments from Monsanto and the Wellcome Trust. […]
The National Center for Genome Resources Studies Childhood Diseases Using febit’s DNA Capture Method
febit’s HybSelect(TM) technology for sequence capture enables targeted Next-Generation Sequencing, furthers development of genetic tests for childhood diseases LEXINGTON, Mass. and HEIDELBERG, Germany, Aug. 10 — The National Center for Genome Resources (NCGR) has selected febit’s DNA-capture method, HybSelect(TM), to re-sequence the exons of genes involved in over 400 of the most devastating childhood diseases […]
Study Performed at Stanford University Published in Nature Biotechnology CAMBRIDGE, Mass.–Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, today announced the publication of a breakthrough study in which a Helicos™ Genetic Analysis System was used to sequence a human genome at the Stanford Institute for Stem Cell and […]
Celebrates Technical Achievements Researchers redefining what’s possible in medical diagnostics and life sciences – Team helps GE to expand Healthcare business NISKAYUNA, N.Y.–From creating a new business in digital pathology to developing next generation diagnostic imaging agents and life sciences tools that are breaking new ground in the detection and treatment of disease, the Biosciences […]
Commercial momentum building for world’s first single molecule sequencer CAMBRIDGE, Mass.–Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, today announced the sale of a Helicos™ Genetic Analysis System to an undisclosed biotechnology company in the Northeast. “This sale marks an important milestone in our development as a commercial […]
454 Life Sciences and Roche NimbleGen Announce Collaboration with Eli Lilly and SeqWright to Sequence Genomic Regions Associated with Psychiatric Disease BRANFORD, Conn.–454 Life Sciences, a Roche company, and Roche NimbleGen, both units of Roche Applied Science, have announced a collaboration with Eli Lilly and Company and SeqWright, a world-wide leader in custom genomic and […]
University of Queensland and Life Technologies Collaborate on Landmark Cancer Research Studies in Australia – Applied Biosystems Advanced Sequencing Technology to Accelerate Pancreatic and Ovarian Cancer Research CARLSBAD, Calif.–The University of Queensland’s Institute for Molecular Bioscience (IMB) and Life Technologies Corporation (NASDAQ:LIFE – News), today announced a strategic scientific research collaboration to study pancreatic and […]
GenomeQuest, Inc. today announced its Sequence Data Management (SDM) product. GenomeQuest 6.0Beta introduces a new category of functionality, accessibility, and methods to genomics researchers and organizations seeking to fundamentally improve the performance of their discovery process and broadly prepare for next generation sequencing (NGS). Westborough, MA (PRWEB) July 28, 2009 — GenomeQuest, Inc. today announced […]
BRANFORD, Conn.–Roche and Google.org recently started a joint project to demonstrate the feasibility of developing a multidisciplinary surveillance, research and response system. This system will enhance the ability to predict and prevent emerging infectious diseases in East Africa. Roche has donated a Genome Sequencer FLX system as backbone of this project.“We are proud to work […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
